Preclinical drug development refers to the stage in which a new drug is tested and evaluated before it can be administered to humans. This phase involves laboratory experiments, animal testing, and other studies to determine the safety, efficacy, and optimal dosage of the drug. The goal of preclinical drug development is to identify any potential risks or side effects that may occur in human subjects and make necessary adjustments before moving on to clinical trials.